Company on track to complete planned interim analyses from two ongoing Phase 2 studies of…
Michelle Robertson to remain with Company until August 16, 2023 Erick Lucera Editas Medicine today…
Michelle Robertson to remain with Company until August 16, 2023 Erick Lucera Editas Medicine today…
DURHAM, N.C., May 16, 2023 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or “the…
DURHAM, N.C., May 16, 2023 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or “the…
HOUSTON, May 16, 2023 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a clinical-stage biopharmaceutical…
HOUSTON, May 16, 2023 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a clinical-stage biopharmaceutical…
CARSON CITY, Nev., May 16, 2023 (GLOBE NEWSWIRE) — BioVie Inc., (NASDAQ: BIVI) (“BioVie” or…
CARSON CITY, Nev., May 16, 2023 (GLOBE NEWSWIRE) — BioVie Inc., (NASDAQ: BIVI) (“BioVie” or…
Call scheduled for Thursday, June 22nd at 4:30 pm Eastern Time GARDEN CITY, N.Y., May…
Call scheduled for Thursday, June 22nd at 4:30 pm Eastern Time GARDEN CITY, N.Y., May…
~60% reduction in annualized infection rate seen in the mavorixafor arm vs. placebo (p<0.01) >75%…
~60% reduction in annualized infection rate seen in the mavorixafor arm vs. placebo (p<0.01) >75%…
VANCOUVER, British Columbia, May 16, 2023 (GLOBE NEWSWIRE) — Mydecine Innovations Group (NEO: MYCO) (OTC:…
VANCOUVER, British Columbia, May 16, 2023 (GLOBE NEWSWIRE) — Mydecine Innovations Group (NEO: MYCO) (OTC:…
BRISBANE, Calif., May 16, 2023 (GLOBE NEWSWIRE) — Annexon, Inc. (Nasdaq: ANNX), a clinical-stage biopharmaceutical…
Cash and cash equivalents at €56.3 million, short-term deposits at €0.7 million2, and long term…
While private company performance has been stronger than expected, are cracks starting to form? CHICAGO–(BUSINESS…
Toronto, Ontario–(Newsfile Corp. – May 16, 2023) – RIWI Corp. (TSXV: RIWI) (OTC Pink: RWCRF)…
Central Java, Indonesia, May 17, 2023 – (ACN Newswire) – Ganjar Pranowo, the Governor of…